» Articles » PMID: 15150773

Psychotic Disorders in Prader-Willi Syndrome

Overview
Specialty Genetics
Date 2004 May 20
PMID 15150773
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The Prader-Willi syndrome (PWS) is a genetically determined developmental disorder caused by abnormalities of the proximal region of chromosome 15q11-13. In a previous study, we reported that psychotic episodes, occurring in 16% of persons with PWS, had an onset in adolescence, never occurred in persons with paternal deletion, and were exclusively associated with maternal uniparental disomy (UPD) or imprinting abnormalities (IM). In order to gain a better understanding of the psychopathology and to further refine the psychiatric diagnosis, we describe in more detail the psychopathological manifestations of six adults with a history of psychotic episodes. All these individuals had a detailed psychiatric examination, including the use of the operational criteria (OPCRIT) checklist. An identifiable subtype of psychotic disorder was associated with PWS. Characteristics include early age of onset, acute onset, polymorphous, and shifting symptomatology and a need for psychiatric hospitalization. The presence of precipitating stress factors and a prodromal phase with physiological symptoms was reported in all patients. Current diagnostic categories do not allow an unequivocal psychiatric diagnosis.

Citing Articles

Long-term effect of growth hormone on sleep-disordered breathing in Malaysian children with Prader-Willi syndrome: a retrospective study.

Tan Y, Azanan M, Hng S, Eg K, Jalaludin M, Thong M J Clin Sleep Med. 2024; 20(8):1291-1299.

PMID: 38557309 PMC: 11294127. DOI: 10.5664/jcsm.11140.


Psychotic illness in people with Prader-Willi syndrome: a systematic review of clinical presentation, course and phenomenology.

Aman L, Lester S, Holland A, Fletcher P Orphanet J Rare Dis. 2024; 19(1):69.

PMID: 38360662 PMC: 10870655. DOI: 10.1186/s13023-024-03026-y.


Neurologic orphan diseases: Emerging innovations and role for genetic treatments.

Kioutchoukova I, Foster D, Thakkar R, Foreman M, Burgess B, Toms R World J Exp Med. 2023; 13(4):59-74.

PMID: 37767543 PMC: 10520757. DOI: 10.5493/wjem.v13.i4.59.


Novel epigenetic molecular therapies for imprinting disorders.

Wang S, Jiang Y Mol Psychiatry. 2023; 28(8):3182-3193.

PMID: 37626134 PMC: 10618104. DOI: 10.1038/s41380-023-02208-7.


Do the diverse phenotypes of Prader-Willi syndrome reflect extremes of covariation in typical populations?.

Salminen I, Read S, Crespi B Front Genet. 2022; 13:1041943.

PMID: 36506301 PMC: 9731222. DOI: 10.3389/fgene.2022.1041943.